Cipla to continue cost cutting via portfolio rationalisation, manufacturing network review

Cipla to continue cost cutting via portfolio rationalisation, manufacturing network review Cipla had exited certain low margin products from the portfolio of its subsidiary Invagen in US.

No comments:

Post a Comment